<SEC-DOCUMENT>0001062822-23-000019.txt : 20230502
<SEC-HEADER>0001062822-23-000019.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502160527
ACCESSION NUMBER:		0001062822-23-000019
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230501
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXICON PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001062822
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				760474169
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30111
		FILM NUMBER:		23878868

	BUSINESS ADDRESS:	
		STREET 1:		2445 TECHNOLOGY FOREST BLVD.
		STREET 2:		SUITE 1100
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381
		BUSINESS PHONE:		2818633000

	MAIL ADDRESS:	
		STREET 1:		2445 TECHNOLOGY FOREST BLVD.
		STREET 2:		SUITE 1100
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON PHARMACEUTICALS, INC./DE
		DATE OF NAME CHANGE:	20070426

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON GENETICS INC/TX
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrx-20230501.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:270d0a33-27ed-479f-b7a0-3c8871793bbb,g:959edbfb-d54a-47b0-ab1a-4d5ebcd9cb0b,d:98c58519cd984e5ba6b7c2a7566be321--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lxrx-20230501</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV80L2ZyYWc6NDdkZWMwOGRlMzUwNDYyN2EyYjY3ZTQxY2FkN2NiZGMvdGFibGU6NTMyNzA3ZGI3YjkzNGZmZWI1OWU5MDcyNjI1MDE5ODgvdGFibGVyYW5nZTo1MzI3MDdkYjdiOTM0ZmZlYjU5ZTkwNzI2MjUwMTk4OF8wLTEtMS0xLTQ0MTY3_98029eae-4a1d-41be-b665-80a5ceb83912">0001062822</ix:nonNumeric><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV80L2ZyYWc6NDdkZWMwOGRlMzUwNDYyN2EyYjY3ZTQxY2FkN2NiZGMvdGFibGU6NTMyNzA3ZGI3YjkzNGZmZWI1OWU5MDcyNjI1MDE5ODgvdGFibGVyYW5nZTo1MzI3MDdkYjdiOTM0ZmZlYjU5ZTkwNzI2MjUwMTk4OF8xLTEtMS0xLTQ0MTY3_81928593-877d-4ae6-9335-170856a87701">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lxrx-20230501.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001062822</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i98c58519cd984e5ba6b7c2a7566be321_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzA0_6d2395f9-feea-4b58-a851-d43d1ace8d89">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8yNjU_6cf727e4-6666-4ec1-b943-bf155950b338">May 1, 2023</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjk1_0af955cd-52db-4f1d-8d74-747b58c5d02b">Lexicon Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:32.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6YTY3ZWZhZjBmNzg1NGFlNDg3ODE1NmVlNDkwODc1Y2MvdGFibGVyYW5nZTphNjdlZmFmMGY3ODU0YWU0ODc4MTU2ZWU0OTA4NzVjY18wLTAtMS0xLTQ0MTY3_3aae5352-46d8-4f02-82b6-40e9dd4b5c59">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6YTY3ZWZhZjBmNzg1NGFlNDg3ODE1NmVlNDkwODc1Y2MvdGFibGVyYW5nZTphNjdlZmFmMGY3ODU0YWU0ODc4MTU2ZWU0OTA4NzVjY18wLTEtMS0xLTQ0MTY3_3180db07-e3f4-4aa2-b643-6395878b83d5">000-30111</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6YTY3ZWZhZjBmNzg1NGFlNDg3ODE1NmVlNDkwODc1Y2MvdGFibGVyYW5nZTphNjdlZmFmMGY3ODU0YWU0ODc4MTU2ZWU0OTA4NzVjY18wLTItMS0xLTQ0MTY3_9c578f39-b51e-4528-8a26-aa9085d9f3ee">76-0474169</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjk2_ab9861b7-d08e-411e-9145-0c4f584788de">2445 Technology Forest Blvd., 11th Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjky_c482f4e9-2d92-4207-9e20-4742f9045d2d">The Woodlands</ix:nonNumeric>, <ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzAx_21783c83-1f35-451d-b7d8-00c18585c70c">Texas</ix:nonNumeric> <ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF80MTk_be16da66-b9cf-4881-b2f2-362f02cca312">77381</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices and Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF80Nzg_a9c75052-527e-4f73-bd7b-676a89f51fa3">281</ix:nonNumeric>) <ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjkw_32c1cd0a-7c9a-45b9-8b22-3874be595da9">863-3000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:34.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6NWNkYjgxMGNmODJiNDg4YmE1Zjg3YmQ1MzVjNzE1YjcvdGFibGVyYW5nZTo1Y2RiODEwY2Y4MmI0ODhiYTVmODdiZDUzNWM3MTViN18xLTAtMS0xLTQ0MTY3_8875f5bc-6017-4a87-a4da-0168fe15f086">Common Stock, par value $0.001</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6NWNkYjgxMGNmODJiNDg4YmE1Zjg3YmQ1MzVjNzE1YjcvdGFibGVyYW5nZTo1Y2RiODEwY2Y4MmI0ODhiYTVmODdiZDUzNWM3MTViN18xLTEtMS0xLTQ0MTY3_e6d79d40-cff6-4041-bb43-020f295c9985">LXRX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6NWNkYjgxMGNmODJiNDg4YmE1Zjg3YmQ1MzVjNzE1YjcvdGFibGVyYW5nZTo1Y2RiODEwY2Y4MmI0ODhiYTVmODdiZDUzNWM3MTViN18xLTItMS0xLTQ0MTY3_2982e476-0a9b-4e10-a86f-fd73cfb9f5b0">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjkx_456e39b4-cf5f-409a-9b04-bc20b6d7b114">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzAy_58e3c8c4-28df-4b50-aad8-0d3d04151e6c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjg5_b16832fd-0f75-46ca-9ab8-e9467bfe0b2c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzAz_2ab761a6-82bc-4206-bb52-16b300b78ef6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjk0_b2f91e7a-f1ec-4700-a5dc-fefd6be40633">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i98c58519cd984e5ba6b7c2a7566be321_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.01 &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Entry into a Material Definitive Agreement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On May 1, 2023, Lexicon and one of its subsidiaries entered into a second amendment to its loan and security agreement with Oxford Finance LLC (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Second Amendment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) increasing the amount available for draw at Lexicon&#8217;s option under the third tranche from $50 million to $75 million and decreasing the amount available for draw at Lexicon&#8217;s option, subject to Oxford&#8217;s consent, under the fourth tranche from $50 million to $25 million.  Under the terms of the Second Amendment, Lexicon and its subsidiaries are subject to an additional financial covenant relating to minimum cash balance requirements following funding of the third tranche and an unused fee will be due in the event Lexicon does not draw the full amount available under the third tranche.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing summary does not purport to be complete and is qualified in its entirety by the Second Amendment, a copy of which is attached to this report as Exhibit 10.1 and incorporated herein by reference.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i98c58519cd984e5ba6b7c2a7566be321_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9.01 &#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:13.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.061%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#8224;10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101secondamendmenttooxf.htm">Second Amendment to Loan and Security Agreement, date May 1, 2023, with Oxford Finance, LLC</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX-104</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by &#8220;[**]&#8221;) has been excluded from this exhibit because it is both not material and would likely cause competitive harm to the Company if publicly disclosed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i98c58519cd984e5ba6b7c2a7566be321_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:52.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lexicon Pharmaceuticals, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:   May 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/ Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">President and General Counsel</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh101secondamendmenttooxf.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibe2ce72ab8b243adb6974819dd8ab1e7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#91;**&#93; Certain information has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">This Second Amendment to Loan and Security Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;) is entered into as of May 1, 2023, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 115 South Union Street, Suite 300, Alexandria, VA  22314 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Oxford</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), as collateral agent (in such capacity, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), the Lenders listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%"> hereof or otherwise a party hereto from time to time including OXFORD FINANCE CREDIT FUND II, LP, by its manager Oxford Finance Advisors, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Credit Fund II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), OXFORD FINANCE CREDIT FUND III, LP, by its manager Oxford Finance Advisors, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Credit Fund III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), OXFORD FINANCE FUNDING IX, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Funding IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), OXFORD FINANCE FUNDING XIII, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Funding XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), and OXFORD FINANCE FUNDING 2023-1, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Funding 2023-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;&#59; together with Credit Fund II, Credit Fund III, Funding IX, and Funding XIII, each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), LEXICON PHARMACEUTICALS, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;) and LEXICON PHARMACEUTICALS (NEW JERSEY), INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Lex-NJ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;), each a Delaware corporation with offices located at 2445 Technology Forest Blvd., 11th Floor, The Woodlands, TX  77381 (Parent and Lex-NJ, individually and collectively, jointly and severally, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:132%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, Collateral Agent, Borrower and the Lenders listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to the Loan Agreement (as defined below) or otherwise a party thereto from time to time including Oxford in its capacity as a Lender have entered into that certain Loan and Security Agreement, dated as of March 17, 2022 (as amended, supplemented or otherwise modified from time to time, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) pursuant to which Lenders have provided to Borrower certain loans in accordance with the terms and conditions thereof&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, Borrower, Lenders and Collateral Agent desire to amend certain provisions of the Loan Agreement as provided herein and subject to the terms and conditions set forth herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NOW, THEREFORE, in consideration of the promises, covenants and agreements contained herein, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Borrower, Lenders and Collateral Agent hereby agree as follows&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Loan Agreement.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Section 13.1 of the Agreement is hereby amended to insert the following defined term in appropriate alphabetical order&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">First Minimum Cash Test Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means &#91;**&#93;&#59; provided that, if Borrower achieves the Minimum Cash Deferral Milestone 1, &#8220;First Minimum Cash Test Date&#8221; shall mean &#91;**&#93;&#59; provided further that, if Borrower achieves the Minimum Cash Deferral Milestone 2, &#8220;First Minimum Cash Test Date&#8221; shall mean &#91;**&#93;.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Minimum Cash Deferral Milestone 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means Borrower&#8217;s receipt of net proceeds prior to &#91;**&#93; of at least &#91;**&#93; (i) from &#91;**&#93; and&#47;or (ii) as proceeds from &#91;**&#93; after the Second Amendment Effective Date and, subject to verification by Collateral Agent. </font></div><div style="text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Minimum Cash Deferral Milestone 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means (i) Borrower has achieved Minimum Cash Deferral Milestone 1 and (ii) Borrower&#8217;s receipt of net proceeds prior to &#91;**&#93; of at least &#91;**&#93; (exclusive of any proceeds received in connection with Minimum Cash Deferral Milestone 1) (a) from &#91;**&#93; and&#47;or (b) as proceeds from &#91;**&#93; after the Second Amendment Effective Date, subject to verification by Collateral Agent. </font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means May 1, 2023.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Unused Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The following defined terms in Section 13.1 of the Agreement hereby are amended and restated in their entireties to read as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; are all of Borrower&#8217;s obligations to pay when due any debts, principal, interest, Lenders&#8217; Expenses, the Prepayment Fee, the Final Payment, the Unused Fee and other amounts Borrower owes the Lenders now or later, in each case, connection with, related to, following, or arising from, out of or under, this Agreement or, the other Loan Documents (other than the Warrants), or otherwise, and including interest accruing after Insolvency Proceedings begin (whether or not allowed) and debts, liabilities, or obligations of Borrower assigned to the Lenders and&#47;or Collateral Agent, and the performance of Borrower&#8217;s duties under the Loan Documents (other than the Warrants).</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Sotagliflozin FDA Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means the FDA&#8217;s approval of the Sotagliflozin NDA for an indication that is no narrower in scope than the Heart Failure Indication plus heart failure in adult patients without type 2 diabetes (that, for clarity, shall include reducing the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in two populations&#58; (i) adults with heart failure and (ii) adults with type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors)&#59; written evidence of which must be provided to, reviewed and approved in writing by Collateral Agent.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Section 2.2(a)(iii) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(iii)        Subject to the terms and conditions of this Agreement, the Lenders agree, severally and not jointly, during the Third Draw Period, to make term loans to Borrower in an aggregate amount up to Seventy Five Million Dollars ($75,000,000.00) according to each Lender&#8217;s Term C Loan Commitment as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereto (such term loans are hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term C Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;, and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term C Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  After repayment, no Term C Loan may be re&#8209;borrowed.&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Section 2.2(a)(iv) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="padding-left:31.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(iv)       Subject to the terms and conditions of this Agreement, upon Borrower&#8217;s written request therefor prior to the Amortization Date, the Lenders may agree, in their sole discretion, severally and not jointly, to make term loans to Borrower in an aggregate amount up to Twenty-Five Million Dollars ($25,000,000.00) according to each Lender&#8217;s Term D Loan Commitment as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereto (such term loans are hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term D Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;, and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term D Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;&#59; each Term A Loan, Term B Loan, Term C Loan or Term D Loan is hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Term A Loans, Term B Loans, Term C Loans and the Term D Loans are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">hereinafter referred to collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  After repayment, no Term D Loan may be re&#8209;borrowed.&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">New Section 2.5(f) hereby is added to the Loan Agreement as follows&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Unused Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. A fee, payable in full on &#91;**&#93; to Lenders, in an amount equal to &#91;**&#93;, if the Third Draw Period expires and Borrower has not drawn the full amount of the Term C Loan (such fee, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Unused Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;). </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Section 3.4 of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3.4        Procedures for Borrowing.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Subject to the prior satisfaction of all other applicable conditions to the making of a Term Loan set forth in this Agreement, to obtain a Term Loan (other than the Term A Loans), Borrower shall notify the Lenders (which notice shall be irrevocable) by electronic mail, facsimile, or telephone by 12&#58;00 p.m. (Noon) EST no later than ten (10) Business Days prior to the date the Term Loan is to be made (or such shorter period as may be agreed to by Collateral Agent).  Together with any such electronic, facsimile or telephonic notification, Borrower shall deliver to the Lenders by electronic mail or facsimile a completed Disbursement Letter executed by a Responsible Officer or his or her designee.  The Lenders may rely on any telephone notice given by a person whom a Lender reasonably believes is a Responsible Officer or designee.  On the Funding Date, each Lender shall credit and&#47;or transfer (as applicable) to the Designated Deposit Account, an amount equal to its Term Loan Commitment.&#8221;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Section 6.10 of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">6.10      Financial Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Minimum &#91;**&#93; Net Product Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  As of the last day of each fiscal quarter ending after the date that is &#91;**&#93; after Sotagliflozin FDA Approval (for the avoidance of doubt, such date after Sotagliflozin FDA Approval is expected to be &#91;**&#93;), Borrower shall achieve actual trailing &#91;**&#93; sotagliflozin net product revenue (excluding any collaboration or royalty revenue) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NPR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), of at least (x) during the first year following Sotagliflozin FDA Approval, &#91;**&#93; of projected sotagliflozin NPR and (y) thereafter, &#91;**&#93; of projected sotagliflozin NPR&#59; in each case, as set forth in the projections attached hereto as Annex X&#59; provided that, once Borrower achieves trailing &#91;**&#93; sotagliflozin NPR of &#91;**&#93; or greater as of the last day of a fiscal quarter ending after the date that is &#91;**&#93; after Sotagliflozin FDA Approval, Borrower shall, as of the last day of each fiscal quarter thereafter, and in lieu of the requirements otherwise set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, achieve trailing &#91;**&#93; sotagliflozin NPR of at least &#91;**&#93;.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Minimum Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.   From and after the Funding Date of the Term C Loan, until Borrower achieves trailing &#91;**&#93; sotagliflozin NPR of at least &#91;**&#93; (such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Minimum Cash Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), Borrower shall maintain minimum unrestricted cash, cash equivalents and short-term investments of at least &#91;**&#93; in Collateral Accounts subject to Control Agreements in favor of Collateral Agent, measured as of the last day of each fiscal quarter beginning with the fiscal quarter ending on the First Minimum Cash Test Date and continuing as of the last day of each fiscal quarter during the Minimum Cash Period.&#8221; </font></div><div style="text-align:justify;text-indent:49.5pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to the Loan Agreement hereby is replaced in its entirety with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> attached hereto. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to the Loan Agreement hereby is replaced in its entirety with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> attached hereto.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Annex X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to the Loan Agreement hereby is replaced in its entirety with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Annex X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> attached hereto. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Limitation of Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;The amendments set forth above are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right, remedy or obligation which Lenders or Borrower may now have or may have in the future under or in connection with any Loan Document, as amended hereby.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, are hereby ratified and confirmed and shall remain in full force and effect.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">To induce Collateral Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Collateral Agent and Lenders as follows&#58; </font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Borrower has the power and due authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">The organizational documents of Borrower delivered to Collateral Agent on the Effective Date, and updated pursuant to subsequent deliveries by or on behalf of the Borrower to the Collateral Agent, remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not contravene (i) any material law or regulation binding on or affecting Borrower, (ii) any material contractual restriction with a Person binding on Borrower, (iii) any material order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (iv) the organizational documents of Borrower&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made and filings required to perfect the security interest of the Collateral Agent in the Collateral&#59; and</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt">This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors&#8217; rights.</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Except as expressly set forth herein, the Loan Agreement shall continue in full force and effect without alteration or amendment.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">As a condition to the effectiveness of this Amendment, Collateral Agent shall have received, in form and substance satisfactory to Collateral Agent, the following&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;this Amendment, duly executed by Borrower&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;resolutions, duly adopted by Borrower&#8217;s board of directors authorizing the entry in to and performance of this Amendment&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;all reasonable Lenders&#8217; Expenses incurred through the date of this Amendment, which may be debited (or ACH&#8217;d) from the Designated Deposit Account in accordance with the Loan Agreement&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;such other documents, and completion of such other matters, as Collateral Agent may reasonably deem necessary or appropriate.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, and all of which, taken together, shall constitute one and the same instrument.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Section 11 of the Loan Agreement (Choice of Law, Venue and Jury Trial Waiver) is incorporated herein by this reference as though set forth in full.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Balance of Page Intentionally Left Blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to the Loan Agreement to be executed as of the date first set forth above.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">BORROWER&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LEXICON PHARMACEUTICALS, INC.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Jeffrey L. Wade</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LEXICON PHARMACEUTICALS (NEW JERSEY), INC.<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; __________________________________________<br>Name&#58; Jeffrey L. Wade<br>Title&#58; President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COLLATERAL AGENT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  _________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Senior Vice President</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">SCHEDULE 1.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Lenders and Commitments</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:32.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term A Loans</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Lender</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term Loan Commitment</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Commitment Percentage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$21,250,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">85.00%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND III, LP</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3,750,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">15.00%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TOTAL</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">$25,000,000.00</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">100.00%</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:32.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term B Loans</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Lender</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term Loan Commitment</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Commitment Percentage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$20,000,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">77.50%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND II</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$1,875,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.50%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND III</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3,750,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">15.00%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TOTAL</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">$25,000,000.00</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">100.00%</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:32.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term C Loans</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Lender</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term Loan Commitment</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Commitment Percentage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$75,000,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">100.00%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TOTAL</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">$75,000,000.00</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">100.00%</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:32.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term D Loans</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Lender</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term Loan Commitment</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Commitment Percentage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$25,000,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">100.00%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TOTAL</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">$25,000,000.00</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">100.00%</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:32.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Aggregate (all Term Loans)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Lender</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Term Loan Commitment</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Commitment Percentage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$146,250,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">97.50%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND III, LP</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3,750,000.00</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.50%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TOTAL</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">$150,000,000.00</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">100.00%</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit C</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Compliance Certificate</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.452%"><tr><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TO&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">OXFORD FINANCE LLC, as Collateral Agent and Lender OXFORD FINANCE CREDIT FUND III, LP, as Lender</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">FROM&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">LEXICON PHARMACEUTICALS, INC., <br>for itself and on behalf of each Borrower</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The undersigned authorized officer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) of LEXICON PHARMACEUTICALS, INC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (for itself and on behalf of each Borrower party to the Loan Agreement (as defined below), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), hereby certifies that in accordance with the terms and conditions of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Loan and Security Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> by and among Borrower, Collateral Agent, and the Lenders from time to time party thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59;&#8221; capitalized terms used but not otherwise defined herein shall have the meanings given them in the Loan Agreement),</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, except as noted below&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as noted below, all representations and warranties of Borrower stated in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are true and correct in all material respects on this date and for the period described in (a), above&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Borrower, and each of Borrower&#8217;s </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, has timely filed all required tax returns and reports, Borrower, and each of Borrower&#8217;s </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, has timely paid all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by Borrower, or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, except as otherwise permitted pursuant to the terms of Section 5.8 of the Loan Agreement&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> have been levied or claims made against Borrower or any of its </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Collateral Agent and the Lenders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Attached are the required documents, if any, supporting our certification(s).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Officer, on behalf of Borrower, further certifies that the attached financial statements are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently applied from one period to the next except as explained in an accompanying letter or footnotes and except, in the case of unaudited financial statements, for the absence of footnotes and subject to year&#8209;end audit adjustments as to the interim financial statements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Please indicate compliance status since the last Compliance Certificate by circling Yes, No, or N&#47;A under &#8220;Complies&#8221; column.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Reporting Covenant</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Requirement</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Actual</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Complies</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Financial statements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Quarterly within 45 days</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Annual (CPA Audited) statements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Within 90 days after FYE</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Annual Financial Projections&#47;Budget (prepared on a monthly basis)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Annually (within 45 days of FYE), and when revised</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A&#47;R &#38; A&#47;P agings</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If applicable</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8&#8209;K, 10&#8209;K and 10&#8209;Q Filings</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If applicable, within 5 days of filing</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Compliance Certificate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Quarterly within 45 days</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">7)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">IP Report</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">When required</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">8)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total amount of Borrower&#8217;s cash and cash equivalents at the last day of the measurement period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$________</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">9)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total amount of Borrower&#8217;s Subsidiaries&#8217; cash and cash equivalents at the last day of the measurement period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$________</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">10)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total amount of cash and other assets maintained at Lion as of the last day of the measurement period</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total amount not to exceed $10,000 at any time per Section 7.12 of the Loan Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$________</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">11)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total amount of Investments made by Borrower in Lion during the current fiscal year as of the last day of the measurement period</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total amount not to exceed $10,000 in any fiscal year per Permitted Investments (k)(ii) of the Loan Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$________</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N&#47;A</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Deposit and Securities Accounts</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">(Please list all accounts&#59; attach separate sheet if additional space needed)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Institution Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Account Number</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">New Account&#63;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Account Control Agreement in place&#63;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">4)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Financial Covenants</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.235%"><tr><td style="width:1.0%"></td><td style="width:4.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.149%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Covenant</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Requirement</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Actual</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Compliance</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Minimum Net Product Revenue</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(trailing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;**&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">or (if applicable) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;**&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">See Section 6.10(a)&#59; Annex X</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Minimum Cash (during Minimum Cash Period)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">See Section 6.10(b)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;**&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Other Matters</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.427%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Have there been any changes in management since the last Compliance Certificate&#63;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Have there been any transfers&#47;sales&#47;disposals&#47;retirement of Collateral or IP prohibited by the Loan Agreement&#63;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Have there been any new or pending claims or causes of action against Borrower that involve more than Five Hundred Thousand Dollars ($500,000.00)&#63;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Have there been any material amendments of or other material changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries&#63; If yes, provide copies of any such amendments or changes with this Compliance Certificate.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exceptions</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please explain any exceptions with respect to the certification above&#58; (If no exceptions exist, state &#8220;No exceptions.&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Attach separate sheet if additional space needed.)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LEXICON PHARMACEUTICALS, INC., </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for itself and on behalf of each Borrower</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                            </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                             </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                               </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">LENDER USE ONLY</font></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Received by&#58; _________________ Date&#58; ____________</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Verified by&#58; __________________ Date&#58; ____________</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Compliance Status&#58;    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">ANNEX X</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Projected Net Product Revenue)   </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;**&#93;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrx-20230501.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:270d0a33-27ed-479f-b7a0-3c8871793bbb,g:959edbfb-d54a-47b0-ab1a-4d5ebcd9cb0b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lxrx="http://lexpharma.com/20230501" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://lexpharma.com/20230501">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20230501_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20230501_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://lexpharma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lxrx-20230501_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:270d0a33-27ed-479f-b7a0-3c8871793bbb,g:959edbfb-d54a-47b0-ab1a-4d5ebcd9cb0b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_c06eb3f4-008b-40d3-8a40-fa9517ce1fca_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8ea49886-334f-4978-a22c-33712245aec0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e50b765e-c7e2-4ef6-aa57-af69b10b0b78_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bb3bbb0c-2e1f-41e2-88ea-a9c12b7a93bd_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d4c74933-0f90-4bb0-a2e0-d4f1c2bf11d5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_5380e417-ec26-426f-97ef-520e50d52f83_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_9a7c8919-85d1-485e-8f6e-d023c0cde17c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_daf76e19-0da0-401a-b305-e4f8f38cf8ae_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8b5e683c-4a93-4639-ace4-1dc00a16cf5a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_05b88e85-0ad6-45b4-8cb7-d3096ce83af9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d75b2ad6-dddf-4a36-8005-ebeb519c0796_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_efea3537-db5e-442e-afd7-63760fcfd306_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_500e1cc0-b4cd-47b7-93bd-c6be10c5e7eb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8b6600c6-23c7-4850-8b79-dd3aceee393a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_20cd5be5-544a-4b01-8130-938a882209b1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7f403f9c-5574-4231-93b3-a81c4e319d61_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_32a562de-ae6d-4c44-8577-174f73a0dfdf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3b3c93e5-24b8-427d-8fd9-3892c7e011b2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c4fb05ee-01e4-431f-b761-0bbe7c27e4bc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_240d039e-803a-4099-9cd9-51882c93b477_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_89e70799-8bd0-45c4-9f8b-146e8396ebca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_a85d71c1-3559-444f-add5-f7cbb1336dd9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>lxrx-20230501_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:270d0a33-27ed-479f-b7a0-3c8871793bbb,g:959edbfb-d54a-47b0-ab1a-4d5ebcd9cb0b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20230501.xsd#Cover"/>
  <link:presentationLink xlink:role="http://lexpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4f39cf88-a3e0-468e-befc-faa1a4ac6fc4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_DocumentType_4f39cf88-a3e0-468e-befc-faa1a4ac6fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a398c9eb-cfa0-4ceb-a278-04070f078a29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityTaxIdentificationNumber_a398c9eb-cfa0-4ceb-a278-04070f078a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0d832947-d689-406b-9d76-c895f5a82c6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityRegistrantName_0d832947-d689-406b-9d76-c895f5a82c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_395bf47b-f34e-4ff4-8387-dc292e33cf75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityFileNumber_395bf47b-f34e-4ff4-8387-dc292e33cf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d41c6f11-f50f-4a6b-a5f8-9d7f1a36aa85" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d41c6f11-f50f-4a6b-a5f8-9d7f1a36aa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e2c65f1f-f0b4-4391-9b82-040b99975632" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityAddressAddressLine1_e2c65f1f-f0b4-4391-9b82-040b99975632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a2936a20-e430-407c-9444-05ad8e83e1cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityAddressCityOrTown_a2936a20-e430-407c-9444-05ad8e83e1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b00ee0e9-6603-4b5f-9edc-ebe3df05bf0d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityAddressStateOrProvince_b00ee0e9-6603-4b5f-9edc-ebe3df05bf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8d2f9856-61b3-4f8d-91b6-468b16592fb1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityAddressPostalZipCode_8d2f9856-61b3-4f8d-91b6-468b16592fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_60fc2c2b-c08a-486e-8645-6885efa834d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_CityAreaCode_60fc2c2b-c08a-486e-8645-6885efa834d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9d176e12-61da-43ae-96a0-ce1052126dac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_LocalPhoneNumber_9d176e12-61da-43ae-96a0-ce1052126dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_50b3651b-afb8-4e64-8feb-e1cc9d71532b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_Security12bTitle_50b3651b-afb8-4e64-8feb-e1cc9d71532b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b5a5c576-da05-4df3-9a6f-78ed84dbc593" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_TradingSymbol_b5a5c576-da05-4df3-9a6f-78ed84dbc593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f96d6ef7-e9bd-41c4-8de3-07b8fe6f86cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_SecurityExchangeName_f96d6ef7-e9bd-41c4-8de3-07b8fe6f86cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c3e7d79d-5faf-4559-85c5-86b56849e72a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_WrittenCommunications_c3e7d79d-5faf-4559-85c5-86b56849e72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_54eb07d5-2bf0-4424-96a3-fb16768e1b36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_SolicitingMaterial_54eb07d5-2bf0-4424-96a3-fb16768e1b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4ee8eda7-a1ec-4216-be6f-46cac3bf3222" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_DocumentPeriodEndDate_4ee8eda7-a1ec-4216-be6f-46cac3bf3222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6a93bf95-15c0-4cad-ac74-b7de6728aa96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_AmendmentFlag_6a93bf95-15c0-4cad-ac74-b7de6728aa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1d5a8154-f819-4109-96ec-e461d6fb85cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityCentralIndexKey_1d5a8154-f819-4109-96ec-e461d6fb85cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f7b01fe7-b038-42e2-a623-e93d8e049c81" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_PreCommencementTenderOffer_f7b01fe7-b038-42e2-a623-e93d8e049c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e106c4c5-1e8a-42cd-b61e-a68e75154f87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e106c4c5-1e8a-42cd-b61e-a68e75154f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3f4f1e0f-1d17-4ed6-a3d2-9016f5b50f68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4bcfb9d8-6b5e-4d53-8bd3-80b43bf2c880" xlink:to="loc_dei_EntityEmergingGrowthCompany_3f4f1e0f-1d17-4ed6-a3d2-9016f5b50f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139794730256704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0474169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lexicon Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2445 Technology Forest Blvd., 11th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">The Woodlands<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">863-3000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LXRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001062822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>lxrx-20230501_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrx-20230501.xsd" xlink:type="simple"/>
    <context id="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001062822</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV80L2ZyYWc6NDdkZWMwOGRlMzUwNDYyN2EyYjY3ZTQxY2FkN2NiZGMvdGFibGU6NTMyNzA3ZGI3YjkzNGZmZWI1OWU5MDcyNjI1MDE5ODgvdGFibGVyYW5nZTo1MzI3MDdkYjdiOTM0ZmZlYjU5ZTkwNzI2MjUwMTk4OF8wLTEtMS0xLTQ0MTY3_98029eae-4a1d-41be-b665-80a5ceb83912">0001062822</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV80L2ZyYWc6NDdkZWMwOGRlMzUwNDYyN2EyYjY3ZTQxY2FkN2NiZGMvdGFibGU6NTMyNzA3ZGI3YjkzNGZmZWI1OWU5MDcyNjI1MDE5ODgvdGFibGVyYW5nZTo1MzI3MDdkYjdiOTM0ZmZlYjU5ZTkwNzI2MjUwMTk4OF8xLTEtMS0xLTQ0MTY3_81928593-877d-4ae6-9335-170856a87701">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzA0_6d2395f9-feea-4b58-a851-d43d1ace8d89">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8yNjU_6cf727e4-6666-4ec1-b943-bf155950b338">2023-05-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjk1_0af955cd-52db-4f1d-8d74-747b58c5d02b">Lexicon Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6YTY3ZWZhZjBmNzg1NGFlNDg3ODE1NmVlNDkwODc1Y2MvdGFibGVyYW5nZTphNjdlZmFmMGY3ODU0YWU0ODc4MTU2ZWU0OTA4NzVjY18wLTAtMS0xLTQ0MTY3_3aae5352-46d8-4f02-82b6-40e9dd4b5c59">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6YTY3ZWZhZjBmNzg1NGFlNDg3ODE1NmVlNDkwODc1Y2MvdGFibGVyYW5nZTphNjdlZmFmMGY3ODU0YWU0ODc4MTU2ZWU0OTA4NzVjY18wLTEtMS0xLTQ0MTY3_3180db07-e3f4-4aa2-b643-6395878b83d5">000-30111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6YTY3ZWZhZjBmNzg1NGFlNDg3ODE1NmVlNDkwODc1Y2MvdGFibGVyYW5nZTphNjdlZmFmMGY3ODU0YWU0ODc4MTU2ZWU0OTA4NzVjY18wLTItMS0xLTQ0MTY3_9c578f39-b51e-4528-8a26-aa9085d9f3ee">76-0474169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjk2_ab9861b7-d08e-411e-9145-0c4f584788de">2445 Technology Forest Blvd., 11th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjky_c482f4e9-2d92-4207-9e20-4742f9045d2d">The Woodlands</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzAx_21783c83-1f35-451d-b7d8-00c18585c70c">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF80MTk_be16da66-b9cf-4881-b2f2-362f02cca312">77381</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF80Nzg_a9c75052-527e-4f73-bd7b-676a89f51fa3">281</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjkw_32c1cd0a-7c9a-45b9-8b22-3874be595da9">863-3000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6NWNkYjgxMGNmODJiNDg4YmE1Zjg3YmQ1MzVjNzE1YjcvdGFibGVyYW5nZTo1Y2RiODEwY2Y4MmI0ODhiYTVmODdiZDUzNWM3MTViN18xLTAtMS0xLTQ0MTY3_8875f5bc-6017-4a87-a4da-0168fe15f086">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6NWNkYjgxMGNmODJiNDg4YmE1Zjg3YmQ1MzVjNzE1YjcvdGFibGVyYW5nZTo1Y2RiODEwY2Y4MmI0ODhiYTVmODdiZDUzNWM3MTViN18xLTEtMS0xLTQ0MTY3_e6d79d40-cff6-4041-bb43-020f295c9985">LXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGFibGU6NWNkYjgxMGNmODJiNDg4YmE1Zjg3YmQ1MzVjNzE1YjcvdGFibGVyYW5nZTo1Y2RiODEwY2Y4MmI0ODhiYTVmODdiZDUzNWM3MTViN18xLTItMS0xLTQ0MTY3_2982e476-0a9b-4e10-a86f-fd73cfb9f5b0">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjkx_456e39b4-cf5f-409a-9b04-bc20b6d7b114">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzAy_58e3c8c4-28df-4b50-aad8-0d3d04151e6c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjg5_b16832fd-0f75-46ca-9ab8-e9467bfe0b2c">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNzAz_2ab761a6-82bc-4206-bb52-16b300b78ef6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie5a773dd1ec746d88661e86170399e24_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjk4YzU4NTE5Y2Q5ODRlNWJhNmI3YzJhNzU2NmJlMzIxL3NlYzo5OGM1ODUxOWNkOTg0ZTViYTZiN2MyYTc1NjZiZTMyMV8xL2ZyYWc6MGM5YzAxZWQ2OGEzNDMwY2E1Y2RmMjAzOTFlZjNiNjQvdGV4dHJlZ2lvbjowYzljMDFlZDY4YTM0MzBjYTVjZGYyMDM5MWVmM2I2NF8xNjk0_b2f91e7a-f1ec-4700-a5dc-fefd6be40633">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "J@*)6!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *J
MHE9G&2P-[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( *J HE:97)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ JH"B5MY] \N!
M!   )!$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( *J HE:?H!OPL0(  .(,   -              "
M <0,  !X;"]S='EL97,N>&UL4$L! A0#%     @ JH"B5I>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  !@4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lxrx-20230501.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lexpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0540-DocumentPeriodEndDate-Value] In submission type 8-K, DocumentPeriodEndDate value "2023-05-01", is not equivalent to header element periodOfReport value "05-02-2023" in the Required Context. lxrx-20230501.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="lxrx-20230501.htm">lxrx-20230501.htm</File>
    <File>exh101secondamendmenttooxf.htm</File>
    <File>lxrx-20230501.xsd</File>
    <File>lxrx-20230501_lab.xml</File>
    <File>lxrx-20230501_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lxrx-20230501.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "lxrx-20230501.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lxrx-20230501_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrx-20230501_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lxrx-20230501.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lxrx",
   "nsuri": "http://lexpharma.com/20230501",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20230501.htm",
      "contextRef": "ie5a773dd1ec746d88661e86170399e24_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://lexpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20230501.htm",
      "contextRef": "ie5a773dd1ec746d88661e86170399e24_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001062822-23-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062822-23-000019-xbrl.zip
M4$L#!!0    ( *J HE8Y\:]BLRH  &KJ 0 >    97AH,3 Q<V5C;VYD86UE
M;F1M96YT=&]O>&8N:'1M[7UK5]O(LO;W]U?T2>;DX+V$8YM[F#UK.<9,F)<
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M'@$ER3NA=8..Z,%@-V"*Z&W0,BY!<!R3<'1RFYFQ> .5Q G!'F0FVL_&ZX(
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M([1W)0&B;-1AQBJ(Q2+P#]VG@>><0BQDCPSCW/YB++&,E7G1RTG%4.X3!M>
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MC?WG:+:QOU><^+EFA9<P5A:3MNS146.&R>I\!L/+.N=\&.*A]=)A\=#,5:#
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MOAD6P^*%&2F1( $X@BY+>%I! ZO=T3<M^EJ2D,#HCJ4!G%]@? TK,'_EO7:
M.X"M-*MYEH,?7/7_C, HO'ECDSC6G' 0<NYT!6F)0O:AS,;G!98B8)%E%  L
M\_TR I!?EB>B%=5)+W"##!$P!?-)KP[(0_L>"&"8&.:ZNH7[A;"TJM>:UU(K
MA==AD#CW&23[5ZPL#TWF["EP,$-*^F,RQ!;[L HB\XVCI3W<N\$7/WB@%RW-
M?(H_1K2B8:[GCSUF6*NH6,[W']4L*N9Z-YV]D7+M!^^Z5NZWRN;2LA%?B\&'
M*R<7_-\?&T 5GGI)(&VM-W?)S(/22SK!OTIK6/\H%.9;N4AEO9U)2UC]^&V;
M$OF!E;1ZGR[V_6?;VGT$^XF^FK6@_,4H?-(C"LF]W2MG-XOCB5_L98-ESU 8
M=8=S'WA>HWP=3]A&XD+B1>_[#K=X6_C%GTKT=E#G.9AW$# 6\@U1>?4O3!3]
M.3AWH]MZ-N;=G#S: _\V05]HEZ.:@#?U9*2L0C.:7V>UQ0<N9VSVBKZ92UJ3
MMAV2K_)CL]NZU[GX:3.)G.6K]^%OE?7[THO[=;7C$LZ<0P'XU1[A4M+X6ZIM
MOG.UA%3BJS98BV32*F$R?"+%I73G3(5LN1^VU ];0? AOY2^.PKS.\:.\1_;
MR /FH<)5CZ[>YH>VYNDX)ASI6=3Q_W[]]?^OXFHB#>=R'HGCD>%($+0,-4E7
MG<],3I=[5.3F EF" "JU)\,'5]6,0OJ/XU'(4!B<\W"*\N8BH,"S/,8L+KC.
M0P <S5+)(B<X'+EAX$$/<(^\,$XY6XW1MY@/(=J&$R+ST>YZD]6R6MG0"WZ.
M804T&R7\@:C#$Z[<7_2PR>VJNPV&(FZ^7R-/C=\(E*Y79[-]5TZ=C>8,R!8"
M;GF0+P4(<I'WD!$]E_=HZ,_C>=(<G#40Y4=\)+(?<CPZRGIQ KMCQ2L-\<)Q
M#[7HV.I3XAZ&6K2U[Q_W,(NZ;GW_J]BMHJYJWS/NL3("8'ZS3_7R_O^#KTQ8
M]OMOJ0]R7U7!$Z(F3VVZ8G7ZJUK=]W;"-V'*B[?DE!&27J@Z?]'+LX49-K'#
MWZ;E'VQ'I;2$?@/3,D*M(MI+1H.G!/2^+YO,%!RXI&6RLMKH+<#VE<'U&^)Y
M#]J&SP!:.6(YR& Z;PU@'_,HB!/T-?#XAJHHY#(>6[CXS%#Y I:^?$VQ]!P/
M>,03\"+%VU%2'JX* JYS7?93W\:U5K\W5K17<F,VA?]ZV2#<^2]02P,$%
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MRG#0NWOC#2P55-/ ;0\>IO9'36AH(QD@KQSLM\"I(TN!>K[-9.":7ZWE:MN
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M>X-CQ'QE&LX;Z'(:J +T[VAUK_<U[Q/ZD:?,4Y8@(YX*K'4Y<.(T%YCYBFB
M2AO,N";A]VT/>[UIPBW#'<DZ+3A.-YLK:+Z="S"J@\2$ET'7#.4A$J\9X(0,
M9 K_ <EDNT3DB0?#0)EP@W&G$D_BSO)V!<TEYL?_:>KK=HF36[OJ)A=))@8T
M$1991B1$39R(G%C*=%)>T:3-#NXOSQH?!LF$VY"[$G9G?+Q9/)'R#'<<[=T=
MZ#ZZ%^&/]OX/4$L! A0#%     @ JH"B5CGQKV*S*@  :NH! !X
M     ( !     &5X:#$P,7-E8V]N9&%M96YD;65N='1O;WAF+FAT;5!+ 0(4
M Q0    ( *J HE;V:#-(,14  'B"   1              "  >\J  !L>')X
M+3(P,C,P-3 Q+FAT;5!+ 0(4 Q0    ( *J HE8(;79H9P(  &4'   1
M          "  4]   !L>')X+3(P,C,P-3 Q+GAS9%!+ 0(4 Q0    ( *J
MHE9'JI3&1PH  !A=   5              "  >5"  !L>')X+3(P,C,P-3 Q
M7VQA8BYX;6Q02P$"% ,4    " "J@*)6,5"UOJH&  #6,   %0
M    @ %?30  ;'AR>"TR,#(S,#4P,5]P<F4N>&UL4$L%!@     %  4 4 $
' #Q4      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
